2m 2m 2m 2m 2m 2m 2m
Cytosorbents (CTSO)
NASDAQ
$4.01-$0.04 (-1.01%)
Price as of Oct 02, 2026 7:30 PM EDT- $13.2MMarket Cap
- -79.42%1-Year Change
- Medical DevicesIndustry
Cytosorbents (CTSO)
$4.01-$0.04 (-1.01%)
CTSO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.05 | ||
Change | -$0.13 (-3.23%) | ||
Open | $4.17 | ||
High | $4.29 | ||
Low | $3.83 | ||
Previous Close | $4.18 | ||
Volume | 12,547 | ||
30-Day Average Volume | 26,853 | ||
1-Week Change | -7.53% | ||
1-Month Change | -47.24% | ||
1-Year Change | -79.42% | ||
3-Year Change | -88.62% | ||
5-Year Change | -97.50% | ||
Fundamentals | |||
Shares Outstanding | 3.2M | ||
Total Assets | $38.0M | ||
Market Cap | $13.2M | ||
Enterprise Value | $26.0M | ||
Period: QTR TTM FY | |||
Revenue | $9.6M | ||
Net Income | -$4.4M | ||
Free Cash Flow | -$597,000.00 | ||
EBIT | -$3.5M | ||
EBITDA | -$3.0M | ||
Net Working Capital | -$8.3M | ||
EPS | -$1.40 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | 3 | ||
P/B | -18 | ||
P/E | -3 | ||
PEG | -0 | ||
Price/Free Cash Flow | -22 | ||
Price/Operating Cash Flow | -23 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 09/08/2026 | ||
Earnings & Revenue